Your browser doesn't support javascript.
loading
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine.
Feola, Sara; Russo, Salvatore; Martins, Beatriz; Lopes, Alessandra; Vandermeulen, Gaëlle; Fluhler, Vinciane; De Giorgi, Camilla; Fusciello, Manlio; Pesonen, Sari; Ylösmäki, Erkko; Antignani, Gabriella; Chiaro, Jacopo; Hamdan, Firas; Feodoroff, Michaela; Grönholm, Mikaela; Cerullo, Vincenzo.
Affiliation
  • Feola S; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Russo S; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Martins B; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Helsinki, Finland.
  • Lopes A; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.
  • Vandermeulen G; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Fluhler V; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • De Giorgi C; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Helsinki, Finland.
  • Fusciello M; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.
  • Pesonen S; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Ylösmäki E; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Antignani G; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Helsinki, Finland.
  • Chiaro J; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.
  • Hamdan F; Advanced Drug Delivery and Biomaterials, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Feodoroff M; Advanced Drug Delivery and Biomaterials, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Grönholm M; Drug Research Program (DRP) ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Cerullo V; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Front Immunol ; 13: 826164, 2022.
Article in En | MEDLINE | ID: mdl-35493448
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Oncolytic Viruses / Oncolytic Virotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Finland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Oncolytic Viruses / Oncolytic Virotherapy / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Finland Country of publication: Switzerland